Creating new products in wake of PPACA

It’s no secret that the Patient Protection and Affordable Care Act has affected the insurance industry from top to bottom. In order to survive and thrive, operators have had to adhere to part of the mantra of the U.S. Marines: adapt and overcome.

One such company, U.S. Advisors Inc. of Brentwood, Tennessee, in August started offering an assurance program to hospitals and surgeons who use a prescription drug called Cellerate, which is used to treat surgical incisions and major lacerations. Cellerate works to speed the healing process so patients who have undergone major surgery recuperate from their incisions faster. It also has been used to prevent amputations performed on diabetics, and as a barrier to prevent further infections.